Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New AI app aims to help NHS patients with sexual problems during long wait times

NCT ID NCT07152847

Symptom relief Sponsor: London Metropolitan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new app that provides education, exercises, and mindfulness tools for people with sexual dysfunction who are on an NHS waiting list for therapy. The app uses artificial intelligence to personalize the experience. Researchers will measure changes in sexual function, well-being, and quality of life over 16 weeks in 150 adults. The goal is to see if the app can offer helpful support while patients wait for professional treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Psychosexual education app with artificial intelligence
What this could lead to
If effective, this app could provide immediate support for people waiting for psychosexual therapy, potentially reducing symptoms and easing strain on NHS services.
What could go wrong
This is a small pilot study with no control group, so results may not be conclusive. The app is not a replacement for therapy, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Must be aged 18 years and above * Must have a laptop, computer, or mobile phone. The App can only be accessed on smartphones and laptops. * Must have been referred to the National Health Service with a psychosexual presentation * Must be currently awaiting psychosexual therapy * Must have been on a National Health Service psychosexual waiting list for less than one month * Must be fluent in reading and writing English, as this is a clinical trial, the investigators wanted to ensure that participants fully understand what was expected. * The Patient Health Questionnaire 2 screening for depression must have a score range between 0 to 2 negative * The Generalised Anxiety Disorder questionnaire 2 screening for anxiety must have a score range between 0 to 2 negative Exclusion Criteria: * Aged below 18 years * Do not possess a mobile phone, computer or laptop * Are not part of a National Health Service referral system * Do not have a psychosexual presentation * Are currently or starting psychosexual therapy * Have difficulties understanding or speaking English * The Patient Health Questionnaire 2 screening outcomes 3 and above * The Generalised Anxiety Disorder questionnaire 2 screening outcomes 3 and above

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sexual dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sexual dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.